What the Clinical Event Committee Does Not See When It Comes to Stent Thrombosis

Circ Cardiovasc Interv. 2016 May;9(5):e003861. doi: 10.1161/CIRCINTERVENTIONS.116.003861.

Authors

Alexandra J Lansky¹, Vivian G Ng²

Affiliations

¹ From the Division of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT. [email protected].
² From the Division of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.

PMID: 27162219
DOI: 10.1161/CIRCINTERVENTIONS.116.003861

No abstract available

Keywords: Editorials; acute coronary syndrome; drug-eluting stents; stent thrombosis; thrombosis.

Publication types

Editorial
Comment

MeSH terms

Angioplasty, Balloon, Coronary
Coronary Thrombosis*
Drug-Eluting Stents*
Humans
Sirolimus / therapeutic use
Stents
Thrombosis / drug therapy
Treatment Outcome

Substances

Sirolimus